Jennifer Johnson

As senior vice president, chief marketing and communications officer at Prime Therapeutics, Jennifer Johnson oversees brand strategy, creative, digital/social media, public relations, product promotion, sales marketing, customer insights and internal/external communications to drive growth, increase market visibility and support retention. 

Following the December 2022 agreement that united Prime and Magellan Rx Management, Johnson assumed leadership of the interim brand strategy and has embraced a rebranding initiative to express the strength and passion of the new enterprise focused on changing health care for the better through connected, values-driven partnership.  

Johnson joined Prime in October 2020 and brings more than 20 years of marketing experience in competitive health care and service industries, including 14 years in progressive leadership roles at UnitedHealth Group. Johnson has experience building and leading high-performing, diverse teams and earned industry recognition for marketing and creative excellence.  

Johnson serves on the board of the Prime Together Foundation, whose mission is to work with the community to address inequality and injustice in all its manifestations, particularly racism, poverty, health and hunger. She is the executive sponsor of the Women + Allies employee resource group, working to build a culture that fosters innovation and learning for women and their allies.  

Johnson earned her Bachelor of Arts degree in communication from the College of Saint Benedict and her mini MBA in business and leadership strategy from the University of St. Thomas.